Gilliam, Frank

Rapid detection of major depression in epilepsy: a multicentre study

Gilliam, F. G., Barry, J. J., Hermann, B. P., Meador, K. J., Vahle, V., & Kanner, A. M. (2006) · The Lancet Neurology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesEpilepsy research and treatment

Cited by 712

Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders

Barry, J. J., Ettinger, A. B., Friel, P., Gilliam, F. G., Harden, C. L., Hermann, B., Kanner, A. M., Caplan, R., Plioplys, S., Salpekar, J., et al. (2008) · Epilepsy & Behavior

Epilepsy research and treatmentTreatment of Major Depression

Cited by 249

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

Kanner, A. M., Barry, J. J., Gilliam, F., Hermann, B., & Meador, K. J. (2010) · Epilepsia

Epilepsy research and treatmentMental Health Treatment and Access

Cited by 182

PEARLS depression treatment for individuals with epilepsy: A randomized controlled trial

Ciechanowski, P., Chaytor, N., Miller, J., Fraser, R., Russo, J., Unutzer, J., & Gilliam, F. (2010) · Epilepsy & Behavior

Mental Health Treatment and AccessEpilepsy research and treatment

Cited by 130

Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy

Chaytor, N., Ciechanowski, P., Miller, J. W., Fraser, R., Russo, J., Unutzer, J., & Gilliam, F. (2011) · Epilepsy & Behavior

Epilepsy research and treatmentMental Health Treatment and Access

Cited by 76

The application of half-life in clinical decision making: comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate

Gidal, B. E., Clark, A. M., Anders, B., & Gilliam, F. (2017) · Epilepsy Research

Pharmaceutical studies and practicesPharmacogenetics and Drug Metabolism

Cited by 26